BIOSEED
DEAD

Serial Number

76169247

Owner

BioTissue Technologies GmbH

Attorney

RAYMOND R. FERERA

Filing Date

Nov 20, 2000

Add to watchlist:

No watchlists yet
View on USPTO

BIOSEED Trademark

Serial Number: 76169247 • Registration: 2708421

BIOSEED is a trademark filed by BioTissue Technologies GmbH on November 20, 2000. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BioTissue Technologies GmbH (3 trademarks)

4b, Engesserstrasse
79108 Freiburg , DE

Entity Type: 99

BioTissue Technologies AG

Bismarckallee 9
79098 Freiburg , DE

Entity Type: 03

Trademark Details

Filing Date

November 20, 2000

Registration Date

April 22, 2003

Published for Opposition

January 28, 2003

Cancellation Date

November 28, 2009

Goods & Services

Surgical implants and transplants comprising artificial material; and sets for the uptake and transport of tissue probes, said kits comprising a temperature controlled transport box, sterile plastic tubes containing an antibiotic buffer, transport solution, cooling and/or freezing elements, labels, monovettes for blood samples, and wrapping material

Pharmaceuticals for the repair, replacement and regeneration of deficient tissue and organs; biomedical preparations, biotechnological preparations, and biomedical preparations produced and modified by genetic engineering, in particular preparations of biological tissue intended for subsequent implantation, namely, bones, bone replacements, cartilage replacements, vessel replacements, tissue replacements, and fatty tissue replacements, all comprising living tissue; surgical implants comprising living tissue; living tissue, cells and molecules produced in vitro for replacing and/or supporting the function of absent or injured body parts; products of tissue engineering, in particular organ replacement products, namely, tissue replacement products comprising living tissue; and biological tissue intended for subsequent implantation, namely, bones, bone replacements, cartilage replacements, vessel replacements, tissue replacements, and fatty tissue replacements, all comprising living tissue

research, development and consultancy in the field of biomedicine and cell culture technology; services in the field of tissue engineering; cell cultivating; cultivating of implants and transplants; services of a cell laboratory, particularly in vitro production of living tissue, cells and/or molecules for replacing and/or supporting the function of absent or injured body parts

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 28, 2009 C8..
CASE FILE IN TICRS
Feb 14, 2008 CFIT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 7, 2006 ASGN
REGISTERED-PRINCIPAL REGISTER
Apr 22, 2003 R.PR
PUBLISHED FOR OPPOSITION
Jan 28, 2003 PUBO
NOTICE OF PUBLICATION
Jan 8, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2002 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2002 CRFA
FINAL REFUSAL MAILED
Apr 23, 2002 CNFR
Sec. 1(B) CLAIM DELETED
Oct 19, 2001 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2001 CRFA
NON-FINAL ACTION MAILED
Apr 19, 2001 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2001 DOCK